News GeNeuro SA

Equities

GNRO

CH0308403085

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:55:00 2026-01-13 am EST			5-day change	1st Jan Change
0.0294 ^EUR	+5.00%		+12.21%	-6.37%

25-10-15	GeNeuro SA Postpones Publication of June 30, 2025 Half-Yearly Financial Report	CI
25-10-15	Geneuro SA postpones publication of half-yearly financial report	RE

25-10-20	GeNeuro : annonce le report de la publication de son rapport semestriel au 30 juin 2025	PU
25-10-15	GeNeuro SA Postpones Publication of June 30, 2025 Half-Yearly Financial Report	CI
25-10-15	Geneuro SA postpones publication of half-yearly financial report	RE
25-10-15	GeNeuro SA Postpones Publication of June 30, 2025 Half-Yearly Financial Report	BU
25-09-29	GeNeuro Secures Debt-restructuring Moratorium Extension from Swiss Court	MT
25-09-26	Geneuro SA announces extension of its definitive Debt Restructuring moratorium	RE
25-09-26	GeNeuro SA Announces the Extension of its Definitive Debt-Restructuring Moratorium	BU
25-08-19	Eclosion2 Fund Reduces Stake in Geneuro Below 10%
25-07-16	Court Orders GeNeuro Subsidiary's Liquidation	MT
25-07-16	GeNeuro SA Announces the Liquidation of Its French Subsidiary GeNeuro Innovation SAS	BU
25-06-30	GeNeuro Announces Approval of All Resolutions Proposed at Extraordinary General Meeting	BU
25-06-13	GeNeuro Subsidiary Placed in Receivership Amid Group Restructuring	MT
25-06-12	GeNeuro : Inside Information / Other news releases	PU
25-06-12	Geneuro SA Announces The Opening Of Receivership Proceedings For Its French Subsidiary Geneuro Innovation Sas	RE
25-06-12	GeNeuro SA Announces the Opening of Receivership Proceedings for Its French Subsidiary GeNeuro Innovation SAS	BU
25-06-10	GeNeuro SA Announces an Extraordinary Shareholders’ Meeting on June 30, 2025	BU
25-05-28	GeNeuro Receives Debt-restructuring Moratorium from Swiss Court	MT
25-05-27	GeNeuro SA Announces Definitive Debt-Restructuring Moratorium	BU
25-05-12	GeNeuro SA Announces the Postponement of the Publication of the Company's 2024 Annual Results	BU
25-01-28	GeNeuro SA Announces Renewal of Provisional Debt-Restructuring Moratorium	BU
25-01-13	Geneuro: Eclosion2 falls below 20%.
24-12-06	New Data Supporting a New Precision Medicine Approach for ALS Patients With GeNeuro’s GNK-301 Presented at the 35th International Symposium on ALS/MND	BU
24-09-30	GeNeuro SA Decides to Postpone the Publication of its June 30, 2024 Half-Yearly Results	CI
24-09-30	GeNeuro SA Obtains the Opening of Debt-Restructuring Proceedings	BU
24-09-20	Geneuro: presentation of new Temelimab data

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

News GeNeuro SA

Equities

GNRO

CH0308403085

Biotechnology & Medical Research

Filters